Dr. Scott Douglas Piette, DO

Dr. Piette practices at Lo Eye Care in East Lansing, Michigan.

Dr. Piette's NPI, 1861423899, was assigned on July 6, 2006. Dr. Piette graduated from Arizona College of Osteopathic Medicine - Glendale in 2000. Dr. Piette holds Florida license OS16827.

Dr. Piette's primary practice is Lo Eye Care, at 2001 Coolidge Rd, East Lansing, MI 48823 in Ingham County. The practice phone is (517) 337-1668.

Dr. Piette's primary practice is Lo Eye Care in East Lansing, Michigan. Dmand AI also links Dr. Piette to 4 medical groups, 2 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Piette practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Piette's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Piette is board certified in ophthalmology by the AOA Board of Ophthalmology and Otolaryngology. Dr. Piette is licensed in Florida.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Piette treats.

CMS data shows 4,063 Medicare services from Dr. Piette across 19 procedure codes in 2024, for 1,065 Medicare patients. Medicare paid $269,299 for them.

CMS counts 1,065 Medicare patients who saw Dr. Piette in 2024. The largest group is 75 to 84, with 466 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Piette's median patient age at 72, with 57% women.

In 2024, Dr. Piette wrote 4,965 Medicare Part D claims for 853 patients. 66% of them were for generic drugs. CMS names the drug for 4,852 of them, across 29 drugs with 11 or more claims each, at $453,860 in total drug cost. In 2023, CMS named 4,226 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Piette for performance year 2024, reported as part of a group. Dr. Piette accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 97 procedures of cataract surgery by Dr. Piette, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Piette, published from 2002 to 2023. The most frequent topics are Glaucoma, Intraocular Pressure and Optic Disk. Dr. Piette has published most often in Am J Ophthalmol. Dr. Piette's most frequent co-authors are Jeffrey M. Liebmann, MD, Wallace Lm Alward, MD and Sahar Bedrood, MD, PhD.

CMS Open Payments shows 261 general payments to Dr. Piette from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Allergan Inc. paid the most, $21,367.

Dmand AI lists 1 award for Dr. Piette, most recently CMS Stage 1 2012 in 2011.

Dr. Piette graduated from Arizona College of Osteopathic Medicine - Glendale in 2000. Dr. Piette is a member of AAO, AOA and ASCRS.

Dr. Piette is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.